NCT07696585Not yet recruiting
New Topical Treatment in Patchy Alopecia Areata
Efficacy and Safety of Topical Therapy of Metformin 30%; Simvastatin 2%; and Betamethasone Valerate 0.1% in Treatment of Patients With Patchy Alopecia Areata
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Sohag University
- Participants (registry)
- 60
- Start
- June 2026 (planned)
- Primary completion
- September 2026
- Study completion
- December 2027 (planned)
- Last registry update
- July 2026
- Countries
- —
Conditions studied: Alopecia Areata
Interventions: topical metformin 30% ointment, Topical Simvastatin 2% ointment, Topical betamethasone valerate 0.1% ointment
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.